Sivem-Irbesartan Product Recall (2021-05-26)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Sivem-Irbesartan 150 mg Tablet
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| KF8325 | B. Sivem-Irbesartan 300 mg Tablet | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
| DIN 02385309 | Tablet | Irbesartan 300mg |
| KC7215 | Sivem-Irbesartan 150 mg Tablet | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
| DIN 02385295 | Tablet | Irbesartan 150mg |
-
Sivem-Irbesartan 150 mg Tablet
-
Sivem-Irbesartan 300 mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.